Testing effectiveness (Phase 2)Ended earlyNCT00708721
What this trial is testing
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Who this might be right for
CancerChronic Myelomonocytic Leukemia
University of Utah 11